share_log

6-K: Update on Adjuvant Br.31 Phase III Trial of Imfinzi in Non-small Cell Lung Cancer

SEC ·  Jun 25 18:15
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.